Fresenius Kabi Recalls Tyenne Injection Vials Due to Glass Particles

Fresenius Kabi has issued a nationwide recall for a lot of Tyenne (tocilizumab-aazg) injection vials after discovering glass particles. Administering contaminated injectable products can cause severe health risks, including blood clots, organ damage, or death. This recall impacts patients using Tyenne for conditions like rheumatoid arthritis and certain COVID-19 cases.